Market Closed

GRCE
Grace Therapeutics
$ 1.81
0.00%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Grace Therapeutics News

Latest Grace Therapeutics Stock News & GRCE Headlines

Grace Therapeutics Announces Second Quarter 2027 Financial Results, Provides Business Update
3 days ago | globenewswire.com
Grace Therapeutics Announces Participation in Upcoming Industry and Investor Events in November 2026
10 days ago | globenewswire.com
Grace Therapeutics Announces First Quarter 2027 Financial Results, Provides Business Update
3 months ago | globenewswire.com
Grace Therapeutics Announces $10 Million Private Placement
3 months ago | globenewswire.com
Grace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration
4 months ago | globenewswire.com
Grace Therapeutics (NASDAQ:GRCE) Trading Down 2.5% – Here’s What Happened
4 months ago | defenseworld.net
Grace Therapeutics Announces 2026 Fiscal Year-End Financial Results, Provides Business Update
5 months ago | globenewswire.com
GRCE Investors Have Opportunity to Join Grace Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
5 months ago | prnewswire.com
GRCE Investors Have Opportunity to Join Grace Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
5 months ago | gurufocus.com
GRCE Investors Have Opportunity to Join Grace Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
5 months ago | prnewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

GRCE
Grace Therapeutics
$ 1.81
0.00%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago